HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 511 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,540,717 | -54.6% | 39,249 | -59.7% | 0.02% | -54.5% |
Q2 2023 | $10,009,156 | -1.2% | 97,318 | +4.8% | 0.04% | -10.2% |
Q1 2023 | $10,133,431 | +144.6% | 92,848 | +155.0% | 0.05% | +122.7% |
Q4 2022 | $4,142,889 | +14.6% | 36,405 | -37.7% | 0.02% | +4.8% |
Q3 2022 | $3,614,000 | -6.9% | 58,397 | +20.0% | 0.02% | -8.7% |
Q2 2022 | $3,880,000 | -18.1% | 48,647 | +8.0% | 0.02% | 0.0% |
Q1 2022 | $4,739,000 | -44.8% | 45,044 | -43.5% | 0.02% | -45.2% |
Q4 2021 | $8,592,000 | -11.0% | 79,730 | -9.5% | 0.04% | -19.2% |
Q3 2021 | $9,654,000 | +33.7% | 88,129 | +14.3% | 0.05% | +30.0% |
Q2 2021 | $7,218,000 | +32.9% | 77,081 | +30.6% | 0.04% | +25.0% |
Q1 2021 | $5,431,000 | +5.0% | 59,011 | -16.5% | 0.03% | +3.2% |
Q4 2020 | $5,171,000 | +94.0% | 70,689 | +106.1% | 0.03% | +63.2% |
Q3 2020 | $2,665,000 | -4.8% | 34,306 | -31.9% | 0.02% | -20.8% |
Q2 2020 | $2,799,000 | +108.7% | 50,364 | +11.2% | 0.02% | +84.6% |
Q1 2020 | $1,341,000 | +164.5% | 45,275 | +223.0% | 0.01% | +225.0% |
Q4 2019 | $507,000 | +62.0% | 14,016 | +21.9% | 0.00% | +33.3% |
Q3 2019 | $313,000 | +31.5% | 11,497 | +16.0% | 0.00% | +50.0% |
Q2 2019 | $238,000 | – | 9,910 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |